Illumina's stock experienced a significant 8.13% plunge during post-market trading on Thursday, following the release of its fourth-quarter and fiscal year 2025 financial results.
While the company reported strong Q4 performance with non-GAAP earnings of $1.35 per diluted share beating the FactSet consensus estimate of $1.24, and revenue of $1.16 billion exceeding the estimated $1.12 billion, investors reacted negatively to the company's fiscal 2026 guidance.
The selloff appears driven by Illumina's mixed outlook, which projects non-GAAP diluted EPS in the range of $5.05 to $5.20 for fiscal 2026, straddling the consensus estimate of $5.06. Although revenue guidance of $4.5 billion to $4.6 billion exceeds the $4.41 billion consensus, the uncertain EPS trajectory prompted investor concern and the subsequent price decline.
Comments